Award notice Supplies

Suministro de Alectinib (DOE), Atezolizumab (DOE), Cobimetinib (DOE), Dornasa alfa (DOE), Pertuzumab (DOE), Polatuzumab vedotina (DOE), Rituximab (DOE) subcutáneo, Vemurafenib (DOE) y Vismodegib (DOE)

Notice published in Spanish. The AI analysis summarises it for you in your language.

Official notice and documents

Public buyer: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Vitoria-Gasteiz
Place of performance: Vitoria-Gasteiz
Estimated value: €31,665,712 excl. VAT
Amount awarded: €21,838,422 excl. VAT
Planned end of contract: 4 September 2030
likely re-tender around March 2030
Bids received: 1
Procedure: Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part.
Publication: 8 September 2026
Notice language: Spanish

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Suministro de Alectinib (DOE), Atezolizumab (DOE), Cobimetinib (DOE), Dornasa alfa (DOE), Pertuzumab (DOE), Polatuzumab vedotina (DOE), Rituximab (DOE) subcutáneo, Vemurafenib (DOE) y Vismodegib (DOE)

Awarded to

ROCHE FARMA, S.A. UNIPERSONAL

9 lots

1 - L1_ALECTINIB (DOE)
2 - L2_ATEZOLIZUMAB (DOE)
3 - L3_COBIMETINIB (DOE)
4 - L4_DORNASA ALFA (DOE)
5 - L5_PERTUZUMAB (DOE)
6 - L6_POLATUZUMAB (DOE)
7 - L7_RITUXIMAB (DOE) SUBCUTÁNEO
8 - L8_VEMURAFENIB (DOE)
9 - L9_VISMODEGIB (DOE)

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below: €350,000
Median: €846,164
A quarter above: €2,267,877

Amounts awarded (excl. VAT) over the last 3 years for 265 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

Contract	Winner	Amount
Suministro de Aflibercept (DOE) Intravítreo 40 mg/ml OSAKIDETZA - Servicio Vasco de Salud - Organización Central · 23 October 2026	Celltrion Farmaceutica SL	€3,108,000
Suministro de Tafasitamab (DOE) OSAKIDETZA - Servicio Vasco de Salud - Organización Central · 23 October 2026	INCYTE BIOSCIENCES IBERIA, S.L.	€2,170,000
Suministro de Tildrakizumab (DOE) OSAKIDETZA - Servicio Vasco de Salud - Organización Central · 23 October 2026	ALMIRALL, S.A.	€19,176,655
Suministro de Asociación Picosulfato sódico (DOE) con óxido de magnesio ligero y ácido cítrico, Povidona iodada (DOE), Levofloxacino (DOE), Anidulafungina (DOE), Fitomenadiona (DOE) Y Epinefrina (DOE) OSAKIDETZA - Servicio Vasco de Salud - Organización Central · 19 October 2026	CASEN RECORDATI SOCIEDAD LIMITADA VEMEDIA PHARMA HISPANIA S A FRESENIUS KABI ESPAÑA, S.A. LABORATORIOS NORMON SA AGUETTANT IBERICA S L	€809,012
Suministro de Quetiapina (DOE), Heparina sódica (DOE), Inmunoglobulina antiD (RH) (DOE), Fentanilo (DOE) inyectable, Cafeína citrato (DOE), Nicotina (DOE) Parche transdérmico y Pazopanib (DOE) OSAKIDETZA - Servicio Vasco de Salud - Organización Central · 16 October 2026	LABORATORIOS NORMON, S.A. LABORATORIOS FARMACEUTICOS ROVI SA REDDY PHARMA IBERIA SA	€515,668

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 618629-2026.